1
|
Mu N, Gu JT, Huang TL, Liu NN, Chen H, Bu X, Zheng ZH, Jia B, Liu J, Wang BL, Wang YM, Zhu ZF, Zhang Y, Zhang YQ, Xue XC, Li M, Zhang W. Blockade of Discoidin Domain Receptor 2 as a Strategy for Reducing Inflammation and Joint Destruction in Rheumatoid Arthritis Via Altered Interleukin-15 and Dkk-1 Signaling in Fibroblast-Like Synoviocytes. Arthritis Rheumatol 2020; 72:943-956. [PMID: 32362074 DOI: 10.1002/art.41205] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2019] [Accepted: 01/09/2020] [Indexed: 12/12/2022]
Abstract
OBJECTIVE This study was undertaken to uncover the pathophysiologic role of discoidin domain receptor 2 (DDR-2), a putative fibrillar collagen receptor, in inflammation promotion and joint destruction in rheumatoid arthritis (RA). METHODS In synovial tissue from patients with RA and from mice with collagen antibody-induced arthritis (CAIA) (using Ddr2-/- and DBA/1 mice), gene and protein expression levels of DDR-2, interleukin-15 (IL-15), and Dkk-1 were measured by quantitative reverse transcription-polymerase chain reaction, Western blotting, and immunohistochemistry. Gene knockdown of DDR2 in human RA fibroblast-like synoviocytes (FLS) was conducted via small interfering RNA. Interaction between the long noncoding RNA H19 and microRNA 103a (miR-103a) was assessed in RA FLS using RNA pulldown assays. Cellular localization of H19 was examined using fluorescence in situ hybridization assays. Chromatin immunoprecipitation and dual luciferase reporter assays were applied to verify H19 transcriptional and posttranscriptional regulation by miR-103a. RESULTS DDR2 messenger RNA (mRNA) expression was significantly associated with the levels of IL-15 and Dkk-1 mRNA in the synovial tissue of RA patients (r2 = 0.2022-0.3293, all P < 0.05; n = 33) and with the serum levels of IL-15 and Dkk-1 in mice with CAIA (P < 0.05). In human RA FLS, activated DDR-2 induced the expression of H19 through c-Myc. Moreover, H19 directly interacted with and promoted the degradation of miR-103a. CONCLUSION These results indicate a novel role for activated DDR-2 in RA FLS, showing that DDR-2 is responsible for regulating the expression of IL-15 and Dkk-1 in RA FLS and is involved in the promotion of inflammation and joint destruction during pathophysiologic development of RA. Moreover, DDR-2 inhibition, acting through the H19-miR-103a axis, leads to reductions in the inflammatory reaction and severity of joint destruction in mice with CAIA, suggesting that inhibition of DDR-2 may be a potential therapeutic strategy for RA.
Collapse
Affiliation(s)
- Nan Mu
- Fourth Military Medical University, Xi'an, China
| | - Jin-Tao Gu
- Fourth Military Medical University, Xi'an, China
| | | | - Nan-Nan Liu
- Fourth Military Medical University, Xi'an, China
| | - Hui Chen
- Fourth Military Medical University, Xi'an, China
| | - Xin Bu
- Fourth Military Medical University, Xi'an, China
| | - Zhao-Hui Zheng
- Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - Bo Jia
- Fourth Military Medical University, Xi'an, China
| | - Jun Liu
- Fourth Military Medical University, Xi'an, China
| | | | - Ying-Mei Wang
- Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - Zhen-Feng Zhu
- Tangdu Hospital, Fourth Military Medical University, Xi'an, China
| | - Yong Zhang
- Tangdu Hospital, Fourth Military Medical University, Xi'an, China
| | | | | | - Meng Li
- Fourth Military Medical University, Xi'an, China
| | - Wei Zhang
- Fourth Military Medical University, Xi'an, China
| |
Collapse
|
2
|
Huang TL, Mu N, Gu JT, Shu Z, Zhang K, Zhao JK, Zhang C, Hao Q, Li WN, Zhang WQ, Liu NN, Zhang Y, Zhang W, Xue XC, Zhang YQ. DDR2-CYR61-MMP1 Signaling Pathway Promotes Bone Erosion in Rheumatoid Arthritis Through Regulating Migration and Invasion of Fibroblast-Like Synoviocytes. J Bone Miner Res 2017; 32:407-418. [PMID: 27653023 DOI: 10.1002/jbmr.2993] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/06/2016] [Revised: 09/02/2016] [Accepted: 09/12/2016] [Indexed: 01/07/2023]
Abstract
Regulation of matrix metalloproteinases (MMPs) by collagen in the fibroblast-like synoviocytes (FLSs) plays a critical role in joint destruction in rheumatoid arthritis (RA). Our previous study indicated that discoidin receptor 2 (DDR2) mediated collagen upregulation of MMPs. However, the precise underlying mechanism remains unclear. We report here that CYR61, a secreted, extracellular matrix-associated signaling protein which is capable of regulating a broad range of cellular activities, including cell adhesion, migration, proliferation, and apoptosis, is significantly upregulated in collagen II-stimulated RA FLS. Further studies found that collagen II-activated phosphorylated-DDR2 induces CYR61 through activation of transcription factor activator protein 1 (AP-1). The elevated CYR61, in turn, accelerates MMP1 production via ETS1 (ETS proto-oncogene 1). In addition, CYR61 significantly promotes FLS invasion and migration. Blockade of CYR61 by an adenovirus expressing CYR61 shRNA (Ad-shCYR61) in vivo remarkably ameliorated the severity of arthritis, reduced inflammatory cytokine secretion, and attenuated bone erosion as detected by micro-computed tomography (μCT), in collagen-induced arthritis (CIA) rats. Taken together, we uncovered the Collagen II-DDR2-AP-1-CYR61-ETS1-MMP1 loop in RA FLS. In which, CYR61 acts as a hinge to promote cartilage damage through regulating FLS invasion, migration, and MMP1 production and the inflammatory cascade in RA. Thus, CYR61 may be a promising diagnostic and therapeutic target for RA treatment. © 2016 American Society for Bone and Mineral Research.
Collapse
Affiliation(s)
- Tong-Lie Huang
- State Key Laboratory of Cancer Biology, Department of Biopharmaceutics, School of Phamacy, Fourth Military Medical University, Xi'an, China
| | - Nan Mu
- State Key Laboratory of Cancer Biology, Department of Biopharmaceutics, School of Phamacy, Fourth Military Medical University, Xi'an, China
| | - Jin-Tao Gu
- State Key Laboratory of Cancer Biology, Department of Biopharmaceutics, School of Phamacy, Fourth Military Medical University, Xi'an, China
| | - Zhen Shu
- State Key Laboratory of Cancer Biology, Department of Biopharmaceutics, School of Phamacy, Fourth Military Medical University, Xi'an, China
| | - Kuo Zhang
- State Key Laboratory of Cancer Biology, Department of Biopharmaceutics, School of Phamacy, Fourth Military Medical University, Xi'an, China
| | - Jin-Kang Zhao
- Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - Cun Zhang
- State Key Laboratory of Cancer Biology, Department of Biopharmaceutics, School of Phamacy, Fourth Military Medical University, Xi'an, China
| | - Qiang Hao
- State Key Laboratory of Cancer Biology, Department of Biopharmaceutics, School of Phamacy, Fourth Military Medical University, Xi'an, China
| | - Wei-Na Li
- State Key Laboratory of Cancer Biology, Department of Biopharmaceutics, School of Phamacy, Fourth Military Medical University, Xi'an, China
| | - Wang-Qian Zhang
- State Key Laboratory of Cancer Biology, Department of Biopharmaceutics, School of Phamacy, Fourth Military Medical University, Xi'an, China
| | - Nan-Nan Liu
- Experiment Teaching Center of Basic Medicine, Fourth Military Medical University, Xi'an, China
| | - Yong Zhang
- Institute of Orthopedics, Tangdu Hospital, Fourth Military Medical University, Xi'an, China
| | - Wei Zhang
- State Key Laboratory of Cancer Biology, Department of Biopharmaceutics, School of Phamacy, Fourth Military Medical University, Xi'an, China
| | - Xiao-Chang Xue
- State Key Laboratory of Cancer Biology, Department of Biopharmaceutics, School of Phamacy, Fourth Military Medical University, Xi'an, China
| | - Ying-Qi Zhang
- State Key Laboratory of Cancer Biology, Department of Biopharmaceutics, School of Phamacy, Fourth Military Medical University, Xi'an, China
| |
Collapse
|
3
|
Zhao W, Zhang C, Shi M, Zhang J, Li M, Xue X, Zhang Z, Shu Z, Zhu J, Mu N, Li W, Hao Q, Wang Z, Gong L, Zhang W, Zhang Y. The discoidin domain receptor 2/annexin A2/matrix metalloproteinase 13 loop promotes joint destruction in arthritis through promoting migration and invasion of fibroblast-like synoviocytes. Arthritis Rheumatol 2014; 66:2355-67. [PMID: 24819400 DOI: 10.1002/art.38696] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2013] [Accepted: 05/02/2014] [Indexed: 12/23/2022]
Abstract
OBJECTIVE Discoidin domain receptor 2 (DDR-2)/matrix metalloproteinase (MMP) signaling is an important pathway involved in cartilage destruction in rheumatoid arthritis (RA). However, the molecular mechanisms of this pathway have not been clearly identified. This study was undertaken to screen key molecules involved in this pathway and evaluate their biologic functions in synovium invasion of RA. METHODS DDR-2-interacting proteins were examined in vitro by immunoprecipitation and mass spectrometry, and annexin A2 was acquired. The effects of annexin A2 on fibroblast-like synoviocyte (FLS) migration were evaluated using a Transwell invasion assay and an Erasion trace test. In Ddr2(-/-) mice with collagen-induced arthritis (CIA), hematoxylin and eosin (H&E) staining, immunohistochemical analysis, and Western blot analysis were used to assess expression of DDR-2, annexin A2, and MMP-13, as well as synovial hyperplasia. Rats with CIA were treated with lentivirus annexin A2 small interfering RNA (siRNA), and annexin A2 siRNA effects on joint damage were analyzed based upon arthritis index scores and results of micro-computed tomography and H&E staining. The differences between annexin A2 expression in clinical samples from RA and osteoarthritis patients were compared using Western blotting. RESULTS Annexin 2 was identified for the first time as a DDR-2 binding protein. It may be phosphorylated by phospho-DDR-2, leading to MMP-13 secretion. The annexin A2 phosphorylation level and MMP-13 expression level were decreased and collagen-induced joint damage greatly reduced in Ddr2(-/-) mice. Joint damage in rats with CIA was significantly ameliorated when annexin A2 was down-regulated. Annexin A2 expression and phosphorylation were elevated in human RA synovial tissue. CONCLUSION Annexin A2 is a key molecule in the DDR-2/annexin A2/MMP-13 loop, the activation of which contributes to joint destruction in RA, mainly through promoting invasion of FLS. Annexin A2 might therefore become a novel clinical target for RA treatment.
Collapse
Affiliation(s)
- Wei Zhao
- Fourth Military Medical University, Xi'an, China, and Ningxia Medical University, Yinchuan, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Binding affinity of full-length and extracellular domains of recombinant human (pro)renin receptor to human renin when expressed in the fat body and hemolymph of silkworm larvae. J Biosci Bioeng 2010; 108:304-9. [PMID: 19716519 DOI: 10.1016/j.jbiosc.2009.04.018] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2009] [Revised: 04/16/2009] [Accepted: 04/17/2009] [Indexed: 11/21/2022]
Abstract
Transmembrane domains of some receptors have been found to be very important in the process of constitutive oligomerization, and in the stability and functioning of the receptor. In this study, full-length of human (pro)renin receptor (hPRR) and hPRR lacking cytoplasmic domain (hPRR-DeltaCD) were expressed in fat body of silkworm larvae, and the extracellular domain of hPRR (hPRR-DeltaTMDeltaCD) in hemolymph. Three forms of hPRR were used for investigation of the interaction between receptor and ligand using surface plasmon resonance (SPR). As a result, the cytoplasmic domain was not an essential requirement for binding affinity, but the transmembrane domain of hPRR was indispensable in the formation of functional hPRR. The dissociation equilibrium constants (K(D)) of purified hPRR and hPRR-DeltaCD were estimated to be 46 nM and 330 nM, respectively. No evidence of binding by the extracellular domain of hPRR located in hemolymph was found. However, the solubilized microsomal fraction of the extracellular domain of hPRR expressed in the fat body showed specific affinity, but lost its binding affinity after purification. Its binding affinity was recovered by mixing microsomal fraction of mock-injected fat body to the purified extracellular domain. It is probable that an artificial transmembrane domain stabilizes the extracellular domain of hPRR and native conformation may be structurally recovered. To our knowledge, these are the first findings describing the interaction of transmembrane and extracellular domains of hPRR with ligand and this may help towards the understanding of binding affinity of hPRR to ligand.
Collapse
|